Patients at-risk for cost-related medication nonadherence: A review of the literature

Journal of General Internal Medicine

Volumn 22, Issue 6, 2007, Pages 864-871

  Briesacher, Becky A ^a   Gurwitz, Jerry H ^a   Soumerai, Stephen B ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cost sharing; Medicare; Patient compliance; Prescriptions

Indexed keywords

BIBLIOGRAPHIC DATABASE; CHRONIC DISEASE; CINAHL; COVARIANCE; DEPRESSION; DOCTOR PATIENT RELATION; DRUG COST; EMPIRICAL RESEARCH; HEALTH ECONOMICS; HEALTH HAZARD; MEDICARE; MEDLINE; MENTAL HEALTH; MOOD DISORDER; PATIENT COMPLIANCE; POLYPHARMACY; PRESCRIPTION; REVIEW; RISK BENEFIT ANALYSIS; STATISTICAL ANALYSIS;

CHRONIC DISEASE; COST OF ILLNESS; COST SHARING; DEPRESSION; HUMANS; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY; PRESCRIPTION FEES; RISK; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; TREATMENT REFUSAL;

EID: 34248562073     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0180-x     Document Type: Review

References (48)

1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. J Am Med Assoc. 2002;287:337-44.
2. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood) 2005.
3. Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42:626-34.
4. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166:1829-35.
5. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care. 2005;11:730-40.
6. Rice T, Matsuoka KY. The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors. Med Care Res Rev. 2004;61:415-52.
7. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. J Am Med Assoc. 2001;285:421-9.
8. Roblin DW, Platt R, Goodman MJ, et al. Effect of increased costsharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care. 2005;43:951-9.
9. Motheral B, Fairman KA. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care. 2001;39:1293-304.
10. Stuart B, Briesacher BA, Shea DG, Cooper B, Baysac FS, Limcangco MR. Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit. Health Aff (Millwood). 2005;24:1022-31.
11. Piette JD, Heisler M, Horne R, Caleb Alexander G. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures. Soc Sci Med. 2006;62:846-57.
12. Craig BM, Kreling DH, Mott DA. Do seniors get the medicines prescribed for them? Evidence from the 1996-1999 Medicare Current Beneficiary Survey. Health Aff (Millwood). 2003;22:175-82.
13. Heisler M, Wagner TH, Piette JD. Clinician identification of chronically ill patients who have problems paying for prescription medications. Am J Med. 2004;116:753-8.
14. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. J Am Med Assoc. 2003;290:953-8.
15. Mitchell J, Mathews HF, Hunt LM, Cobb KH, Watson RW. Mismanaging prescription medications among rural elders: the effects of socioeconomic status, health status, and medication profile indicators. Gerontologist. 2001;41:348-56.
16. Kennedy J, Erb C. Prescription noncompliance due to cost among adults with disabilities in the United States. Am J Public Health. 2002;92:1120-4.
17. Kennedy J, Coyne J, Sclar D. Drug affordability and prescription noncompliance in the United States: 1997-2002. Clin Ther. 2004;26:607-14.
18. Fortess EE, Soumerai SB, McLaughlin TJ, Ross-Degnan D. Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice setting. J Am Geriatr Soc. 2001;49:793-7.
19. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164:1749-55.
20. Schommer JC, Mott DA, Hansen RA, Cline RR. Selected characteristics of senior citizens prescription drug payment and procurement in 1998 and 2001. J Manag Care Pharm. 2003;9:408-15.
21. Landsman PB, Yu W, Liu X, Teutsch SM, Berger ML. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. Am J Manag Care. 2005;11:621-8.
22. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescriptiondrug utilization and spending. N Engl J Med. 2003;349:2224-32.
23. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. J Am Med Assoc. 2004;291:2344-50.
24. Balkrishnan R, Byerly WG, Camacho FT, Shrestha A, Anderson RT. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population. Am J Manag Care. 2001;7:1093-100.
25. Love J. Filling the Rx: An Analysis of the Perceptions, Attitudes and Buying Habitts of Medicare Beneficiaries. Washington, DC: AARP; 2004:1-17.
26. Rector TS, Venus PJ. Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health Aff (Millwood). 2004;23:213-22.
27. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384-91.
28. Cox ER, Jernigan C, Coons SJ, Draugalis JL. Medicare beneficiaries' management of capped prescription benefits. Med Care. 2001;39: 296-301.
29. Klein D, Turvey C, Wallace R. Elders who delay medication because of cost: health insurance, demographic, health, and financial correlates. Gerontologist. 2004;44:779-87.
30. Mojtabai R, Olfson M. Medication Costs, Adherence, And Health Outcomes Among Medicare Beneficiaries. Health Aff. 2003;22:220-9.
31. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood). 2002; Supp Web Exclusives: W253-68.
32. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16:793-9.
33. Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. J Am Med Assoc. 2004;292:952-60.
34. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94:1782-7.
35. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42:102-9.
36. Piette JD, Heisler M. Problems due to medication costs among va and non-va patients with chronic illnesses. Am J Manag Care. 2004;10 (part 2):861-868.
37. Sharkey JR, Ory MG, Browne BA. Determinants of self-management strategies to reduce out-of-pocket prescription medication expense in homebound older people. J Am Geriatr Soc. 2005;53:666-74.
38. Heisler M, Wagner TH, Piette JD. Patient strategies to cope with high prescription medication costs: who is cutting back on necessities, increasing debt, or underusing medications? J Behav Med. 2005;28:43-51.
39. Piette JD, Heisler M. The relationship between older adults' knowledge of their drug coverage and medication cost problems. J Am Geriatr Soc. 2006;54:91-6.
40. Saver B, Doescherm M, Jackson E, Fishman P. Seniors with chronic health conditions and prescription drugs: benefits, wealth, and health. Value Health. 2004;7:113-143.
41. Wilson IB, Rogers WH, Chang H, Safran DG. Cost-related skipping of medications and other treatments among Medicare beneficiaries between 1998 and 2000. Results of a national study. J Gen Intern Med. 2005;20:715-20.
42. Taira DA, Iwane KA, Chung RS. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage. Am J Manag Care. 2003;9:305-12.
43. Piette JD, Heisler M, Krein S, Kerr EA. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165:1749-55.
44. Tseng CW, Brook RH, Keeler E, Mangione CM. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients. JAMA. 2003;290:222-7.
45. Newhouse JP, Manning WG, Duan N, et al. The findings of the Rand Health Insurance experiment - a response to Welch et al. Med Care. 1987;25:157-79.
46. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-9.
47. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity. N Engl J Med. 1987;317:550-6.
48. DeNavas-Walt C, Proctor BD, Lee CH. Income, Poverty, and Health Insurance Coverage in the United States: 2004 Current Population Reports. Washington, DC: U.S. Census Bureau; 2005.